 | Up a level |
Journal Article
Dieckmann, Klaus-Peter, Pokrivcak, Tomas, Geczi, Lajos, Niehaus, David, Dralle-Filiz, Inken, Matthies, Cord, Dienes, Tamas, Zschaebitz, Stefanie, Paffenholz, Pia, Gschliesser, Tanja, Pichler, Renate, Mego, Michal, Bader, Pia, Zengerling, Friedemann, Heinzelbecker, Julia 
ORCID: 0000-0001-8993-7171, Krausewitz, Philipp, Krege, Susanne, Aurilio, Gaetano, Aksoy, Cem, Hentrich, Marcus, Seidel, Christoph, Toerzsoek, Peter, Nestler, Tim, Majewski, Matthaeus, Hiester, Andreas, Buchler, Tomas, Vallet, Sonia ORCID: 0000-0003-0146-8089, Studentova, Hana, Schoenburg, Sandra, Niedersuess-Beke, Dora, Ring, Julia, Trenti, Emanuela ORCID: 0000-0003-3034-531X, Heidenreich, Axel, Wuelfing, Christian, Isbarn, Hendrik, Pichlmeier, Uwe and Pichler, Martin
(2022).
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.
Ther. Adv. Med. Oncol., 14.
LONDON:
SAGE PUBLICATIONS LTD.
ISSN 1758-8359